Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

199.29
Delayed Data
As of Jul 30
 +0.53 / +0.27%
Today’s Change
150.06
Today|||52-Week Range
208.88
+7.71%
Year-to-Date

Today’s Trading

Previous close198.76
Today’s open200.41
Day’s range189.40 - 203.06
Volume2,578,733
Average volume (3 months)2,255,571
Market cap$46.0B
Dividend yield--
Data as of 07/30/2015

Growth & Valuation

Earnings growth (last year)+156.69%
Earnings growth (this year)-4.33%
Earnings growth (next 5 years)+22.38%
Revenue growth (last year)+46.49%
P/E ratio68.3
Price/Sales16.84
Price/Book12.27

Competitors

 Today’s
change
Today’s
% change
SHPGShire-0.86-0.33%
VRTXVertex Pharmaceutica...+9.84+7.83%
PRGOPerrigo Company PLC-1.40-0.73%
MYLMylan NV-0.89-1.55%
Data as of 07/30/2015

Financials

Next reporting dateOctober 22, 2015
EPS forecast (this quarter)$1.11
Annual revenue (last year)$2.2B
Annual profit (last year)$656.9M
Net profit margin29.66%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
David L. Hallal
Chief Financial Officer &
Executive Vice President
Vikas Sinha
Corporate headquarters
Cheshire, Connecticut

Forecasts